Semochkin S.V. Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma. Clinical Oncohematology. 2024;16(3):229-241. doi:10.21320/2500-2139-2023-16-3-229-241